NOBILI, ELISABETTA
 Distribuzione geografica
Continente #
AS - Asia 2.350
NA - Nord America 2.186
EU - Europa 1.448
AF - Africa 140
SA - Sud America 101
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 3
Totale 6.234
Nazione #
US - Stati Uniti d'America 2.163
VN - Vietnam 995
SG - Singapore 501
CN - Cina 481
GB - Regno Unito 372
SE - Svezia 180
DE - Germania 165
IT - Italia 161
HK - Hong Kong 128
FR - Francia 107
IN - India 93
RU - Federazione Russa 85
IE - Irlanda 72
CH - Svizzera 69
NL - Olanda 68
BR - Brasile 66
ZA - Sudafrica 41
UA - Ucraina 37
FI - Finlandia 33
JP - Giappone 33
TG - Togo 33
SC - Seychelles 31
EE - Estonia 29
BG - Bulgaria 26
KR - Corea 26
AR - Argentina 17
CI - Costa d'Avorio 16
CA - Canada 15
IQ - Iraq 12
JO - Giordania 12
BE - Belgio 11
NG - Nigeria 11
TH - Thailandia 10
AT - Austria 8
BD - Bangladesh 8
TR - Turchia 7
MX - Messico 6
PH - Filippine 6
EC - Ecuador 5
ID - Indonesia 5
TW - Taiwan 5
CL - Cile 4
IR - Iran 4
LT - Lituania 4
SA - Arabia Saudita 4
VE - Venezuela 4
AU - Australia 3
EU - Europa 3
GR - Grecia 3
LB - Libano 3
PK - Pakistan 3
PL - Polonia 3
RO - Romania 3
XK - ???statistics.table.value.countryCode.XK??? 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
CZ - Repubblica Ceca 2
EG - Egitto 2
ES - Italia 2
HR - Croazia 2
JM - Giamaica 2
KZ - Kazakistan 2
MA - Marocco 2
NP - Nepal 2
PE - Perù 2
PS - Palestinian Territory 2
PY - Paraguay 2
SK - Slovacchia (Repubblica Slovacca) 2
UZ - Uzbekistan 2
BO - Bolivia 1
DK - Danimarca 1
DZ - Algeria 1
ET - Etiopia 1
HU - Ungheria 1
IL - Israele 1
KE - Kenya 1
KG - Kirghizistan 1
MU - Mauritius 1
PT - Portogallo 1
RS - Serbia 1
Totale 6.234
Città #
Singapore 343
Southend 327
Ho Chi Minh City 254
Ashburn 243
Chandler 214
Hanoi 195
Fairfield 155
Santa Clara 133
Hong Kong 122
Dong Ket 112
San Jose 104
Wilmington 91
Woodbridge 87
Houston 81
Princeton 80
Seattle 75
Beijing 73
Dublin 72
Ann Arbor 68
Bern 63
Boardman 54
New York 44
Cambridge 39
Hefei 34
Westminster 34
Lauterbourg 33
Lomé 33
Los Angeles 32
Padova 30
Nanjing 29
Helsinki 28
Sofia 26
Shenyang 24
Bologna 23
Haiphong 23
Tokyo 22
Turin 22
Medford 21
Jacksonville 19
Milan 19
Da Nang 18
Saint Petersburg 17
Abidjan 16
Frankfurt am Main 16
Changsha 15
Hebei 15
Jinan 15
Seoul 15
Guangzhou 14
Ha Long 14
San Diego 14
Shanghai 14
Berlin 13
Des Moines 13
Buffalo 12
Hải Dương 12
Redondo Beach 12
Abeokuta 11
Amman 11
Brussels 11
Biên Hòa 10
Bắc Giang 10
Florence 10
Nanchang 10
Ninh Bình 10
Thái Nguyên 10
Falls Church 9
Jiaxing 9
Munich 9
Quận Bình Thạnh 9
Redwood City 9
Tianjin 9
Zhengzhou 9
Can Tho 8
Council Bluffs 8
Hangzhou 8
Kuban 8
Norwalk 8
Vũng Tàu 8
Bắc Ninh 7
Bến Tre 7
Mülheim 7
Orem 7
Quận Một 7
São Paulo 7
Dallas 6
Falkenstein 6
Fremont 6
London 6
Phủ Lý 6
Quận Mười 6
Johannesburg 5
Monmouth Junction 5
Montreal 5
Paris 5
Rome 5
Taiyuan 5
Toronto 5
Turku 5
Tân Tiến 5
Totale 4.053
Nome #
Vaccine-Based Immunotherapy for Oropharyngeal and Nasopharyngeal Cancers 654
A case of complete response to nivolumab after long-term progression-free survival with tyrosine kinase inhibitor. 228
Venous thromboembolism and port-related thrombosis in metastatic colorectal cancer patients: a monocenter experience. 205
Cell proliferation and ultrastructural changes of the duodenal mucosa of patients affected by familial adenomatous polyposis. 201
Autoimmune pancreatitis associated with high levels of chromogranin a, serotonin and 5-hydroxyindoleacetic Acid 189
Clinical management of a pituitary gland metastasis from clear cell renal cell carcinoma. 184
Liver metastases from prostate cancer at 11C-Choline PET/CT: a multicenter, retrospective analysis 184
Breast carcinoma presenting as linitis plastica 173
Capecitabine(CAP) based regimens vs infusional 5FU/AF in metastatic colorectal cancer cost/effectivness: the differences across the atlantic ocean 166
Advanced pancreatic cancer (APC) A monocenter experience in 53 patients: is it possible a second line treatment? 166
Spontaneous regression of a desmoid intraabdominal tumor in a patient affected by familial adenomatous polyposis. 164
KRAS and BRAF mutational status as selective criteria for targeted therapy in cholangiocarcinoma. 163
The Protease Inhibitor Gabexate Mesylate Reduces Invasiveness and Angiogenesis in Pancreatic Cancer Cell Lines, Enhancing Gemcitabine Action 161
Single-agent carboplatin in extensive disease small-cell lung cancer patient with liver failure: A case report within the experience of a single institution 160
Impact of adjuvant chemotherapy on time to relapse in cholangiocarcinoma. 159
Gemox in combination witherlotinib (E) in pancreatic cancer (PC). 158
Bevacizumab plus octreotide and metronomic capecitabine in patients with metastatic well-to-moderately differentiated neuroendocrine tumors: the xelbevoct study. 157
High prevalence of asbestos exposure in bile duct cancer patients 157
Advanced pancreatic cancer (apc); a Monocenter experience in 53 patients. It is possible a second line treatment? 156
GEMOX AS FIRST-LINE CHEMOTHERAPY IN ADVANCED PANCREATIC CANCER (APC): A MONOINSTITUTIONAL EXPERIENCE 151
EXOCRINE-ENDOCRINE PANCREATIC CANCER AND alpha-FETOPROTEIN 151
Impact of surgery on the development of duodenal cancer in patients with familial adenomatous polyposis. 151
Metastatic pancreatic cancer: is gemcitabine still the best standard treatment? 150
Detection of liver lesions during 11C-Choline PET/CT in relapsing prostate cancer patients 148
Role of adjuvant chemoradiotherapy (CRT) and chemotherapy alone in pancreatic cancer: experience in 25 patients. 146
Effect of the serine proteases inhibitor gabexate mesylate (GM) on the activity of gemcitabine (G) in cell lines of pancreatic cancer (PC) 145
Hyperammonemic encephalopathy during XELOX regimen. Is it capecitabine or oxaliplatin responsible? 145
Nanotechnology-Related environment, health and safety Research 133
Critical diagnostic delay associated with unusual presentation of hepatocellular carcinoma (Hcc) with orbital metastases: A case report 129
Systemic adjuvant chemotherapy after resection of colorectal cancer metastases 126
GEMOX AS FIRST-LINE CHEMOTHERAPY IN ADVANCED PANCREATIC CANCER (APC): A MONOISTITUTIONAL EXPERIENCE. 122
METRONOMIC CAPECITABINE IN HEPATOCELLULAR CARCINOMA RELAPSE AFTER LIVER TRANSPLANTATION: A RETROSPECTIVE STUDY 121
IMPACT OF MULTIDISCIPLINARY APPROACH ON SURVIVAL OF PATIENTS WITH KLATSKIN TUMOR 121
THE RISK OF DUODENAL CANCER IN FAMILIAL ADENOMATOUS POLYPOSIS (FAP) 120
TO WIDEN THE SETTING OF CANCER PATIENTS WHO BENEFIT FROM METRONOMIC CAPECITABINE 118
The protease inhibitor gabexate Mesylate has antitumor effects and enhances gemcitabine action on pancreatic cancer cell lines 112
Improving IMDC Prognostic Prediction Through Evaluation of Initial Site of Metastasis in Patients With Metastatic Renal Cell Carcinoma 111
PATINUM-BASED CHEMOTHERAPY FOR THE TREATMENT OF HIGH-GRADE GASTROINTESTINAL AND UNKNOWN PRIMARY NEUROENDOCRINE NEOPLASMS 104
Improving IMDC Prognostic Prediction Through Evaluation of Initial Site of Metastasis in Patients With Metastatic Renal Cell Carcinoma 53
Totale 6.342
Categoria #
all - tutte 15.880
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.880


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021250 0 0 0 0 0 0 0 0 0 18 11 221
2021/2022737 64 28 26 55 59 42 13 45 44 63 180 118
2022/2023883 85 114 35 100 53 64 25 51 142 40 89 85
2023/2024246 18 28 12 27 19 83 14 22 4 10 4 5
2024/2025795 17 107 72 66 186 45 30 6 8 92 25 141
2025/20262.164 207 560 145 111 223 109 162 56 445 146 0 0
Totale 6.342